Indication of post-chemotherapy retroperitoneal lymph-node dissection (RPLND) in the treatment of non-seminomatous germ-cell tumors of the testis (NSGCTT):: The case of minimal initial and residual disease.

被引：0
|
作者：
Tavernier, E [1 ]
Fléchon, A [1 ]
Méeus, P [1 ]
Rivoire, M [1 ]
Droz, JP [1 ]
机构：
[1] Ctr Leon Berard, F-69373 Lyon, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4599
引用
收藏
页码：406S / 406S
页数：1
相关论文
共 50 条
  • [21] Clinical outcomes in patients with post-chemotherapy residual non-retroperitoneal (RP) disease in non-seminomatous germ-cell tumors (NSGCT)
    King, Jennifer
    Ashkar, Ryan
    Kesler, Kenneth
    Althouse, Sandra K.
    Hanna, Nasser H.
    Einhorn, Lawrence H.
    Adra, Nabil
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [22] The incidence and implications of disease outside a modified template in men undergoing post-chemotherapy retroperitoneal lymph node dissection (PC-RPLND) for metastatic non-seminomatous germ cell tumors (NSGCT)
    Carver, BS
    Shayegan, B
    Motzer, RJ
    Stasi, J
    Bajorin, DF
    Bosl, GJ
    Sheinfeld, J
    JOURNAL OF UROLOGY, 2006, 175 (04): : 192 - 192
  • [23] TESTICULAR RADIOMICS CORRELATED WITH PATHOLOGY AT TIME OF POST-CHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION FOR NON-SEMINOMATOUS GERM CELL TUMOR
    Venishetty, Nikit
    Taylor, Jacob
    Xi, Yin
    Howard, Jeffrey
    Ng, Yeeseng
    Bagrodia, Aditya
    JOURNAL OF UROLOGY, 2023, 209 : E690 - E691
  • [24] LAPAROSCOPIC LYMPH NODE RESECTION OF POST-CHEMOTHERAPY (POST-CHT) RESIDUAL RETROPERITONEAL (RP) TUMOR MASSES IN PATIENTS WITH NON-SEMINOMATOUS TESTICULAR GERM-CELL TUMORS (NSTGCT)
    Sullivan, I. G.
    Anguera, G.
    Arqueros, C.
    Condori, D.
    Palou, J.
    Pena, J. A.
    Villavicencio, H.
    Maroto, P.
    ANNALS OF ONCOLOGY, 2012, 23 : 292 - 292
  • [25] NON-SEMINOMATOUS GERM-CELL TUMORS OF THE TESTIS - ANALYSIS OF AFP AND HCG PRODUCTION BY PRIMARY TUMORS AND RETROPERITONEAL LYMPH-NODE METASTASES AFTER PVB COMBINATION CHEMOTHERAPY
    SUURMEIJER, AJH
    OOSTERHUIS, JW
    MARRINK, J
    DEBRUIN, HWA
    KOOPS, HS
    SLEIJFER, DT
    FLEUREN, GJ
    ONCODEVELOPMENTAL BIOLOGY AND MEDICINE, 1983, 4 (04): : 289 - 308
  • [26] CONTEMPORARY SERIES OF OPEN AND LAPAROSCOPIC RETROPERITONEAL LYMPH-NODE DISSECTION (RPLND) IN CLINICAL STAGE I NON-SEMINOMATOUS GERM-CELL TUMORS OF THE TESTIS (NSGCTS): DATA FROM A SINGLE INSTITUTION.
    Nicolai, Nicola
    Biasoni, Davide
    Aguilera, Jhonny Piedra
    Necchi, Andrea
    Piva, Luigi
    Stagni, Silvia
    Torelli, Tullio
    Pizzocaro, Giorgio
    Milani, Angelo
    Salvioni, Roberto
    JOURNAL OF UROLOGY, 2009, 181 (04): : 323 - 324
  • [27] Laparoscopic retroperitoneal lymph node dissection (L-RPLND) in clinical stage I non-seminomatous germ-cell tumours of the testis (NSGCTT): Towards the mini-invasive single strategy option
    Nicolai, N.
    Biasoni, D.
    Catanzaro, M. A.
    Stagni, S.
    Torelli, T.
    Piva, L.
    Milani, A.
    Necchi, A.
    Raggi, D.
    Giannatempo, P.
    Colecchia, M.
    Paolini, B.
    Salvioni, R.
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E407 - U895
  • [28] Robot-assisted retroperitoneal Lymph-Node Dissection (RPLND) for post-chemotherapy testis cancer residual masses: A monocentric experience
    Khaddad, A.
    Deslandes, M.
    Alezra, E.
    Capon, G.
    Bernhard, J-C
    Robert, G.
    Bladou, F.
    EUROPEAN UROLOGY, 2022, 81 : S846 - S846
  • [29] Testicular radiomics correlated with pathology at time of post-chemotherapy retroperitoneal lymph node dissection for non-seminomatous germ cell tumor.
    Taylor, Jacob
    Venishetty, Nikit
    Xi, Yin
    Howard, Jeffrey
    Ng, Yee Seng
    Bagrodia, Aditya
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [30] NON-SEMINOMATOUS GERM-CELL TUMORS OF TESTIS - PROGNOSTIC VALUE OF EXTENT OF RETROPERITONEAL NODE METASTASES
    BOYLE, LE
    SAMUELS, ML
    JOHNSON, DE
    HUSSEY, DH
    HOLOYE, PY
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1976, 17 (MAR): : 267 - 267
12345